| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
36,340,000 |
| Market
Cap: |
45.79(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.26 - $1.26 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Forte Biosciences is a biopharmaceutical company that had been advancing through clinical trials its product candidate, FB-401, which is a topical live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis. Co. also has been developing its FB-102 program that addresses certain autoimmune diseases such as vitiligo and alopecia areata.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
118,865 |
118,865 |
218,865 |
| Total Buy Value |
$0 |
$75,040 |
$75,040 |
$179,712 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
9 |
9 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wagner Paul A. |
SEE REMARKS |
• • – |
2024-04-01 |
4 |
D |
$0.71 |
$1,735 |
D/D |
(2,453) |
1,879,174 |
|
- |
|
| Wagner Paul A. |
SEE REMARKS |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
1,881,627 |
|
- |
|
| Riley Anthony A |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$0.71 |
$2,367 |
D/D |
(3,345) |
194,474 |
|
- |
|
| Riley Anthony A |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
197,819 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2024-01-01 |
4 |
D |
$0.82 |
$3,156 |
D/D |
(3,841) |
188,444 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
192,285 |
|
- |
|
| Chen Hubert C |
See remarks |
• – – |
2024-01-01 |
4 |
D |
$0.82 |
$2,525 |
D/D |
(3,073) |
93,405 |
|
- |
|
| Chen Hubert C |
See remarks |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
96,478 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2024-01-01 |
4 |
D |
$0.82 |
$3,376 |
D/D |
(4,109) |
1,850,377 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
1,854,486 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-18 |
4 |
B |
$0.75 |
$7,525 |
D/D |
10,000 |
1,823,236 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-14 |
4 |
B |
$0.72 |
$7,200 |
D/D |
10,000 |
1,813,236 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-13 |
4 |
B |
$0.70 |
$7,351 |
D/D |
10,520 |
1,803,236 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-12 |
4 |
B |
$0.65 |
$3,088 |
D/D |
4,776 |
1,792,716 |
2.73 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-11 |
4 |
B |
$0.65 |
$16,188 |
D/D |
25,000 |
1,787,940 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-08 |
4 |
B |
$0.62 |
$9,300 |
D/D |
15,000 |
1,762,940 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-12-07 |
4 |
B |
$0.58 |
$21,168 |
D/D |
36,203 |
1,747,940 |
2.81 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-11-22 |
4 |
B |
$0.43 |
$172 |
D/D |
400 |
1,711,737 |
2.73 |
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-11-20 |
4 |
B |
$0.43 |
$3,048 |
D/D |
6,966 |
1,711,337 |
2.73 |
- |
|
| Chen Hubert C |
See remarks |
• – – |
2023-10-01 |
4 |
D |
$0.66 |
$1,717 |
D/D |
(2,593) |
88,978 |
|
- |
|
| Chen Hubert C |
See remarks |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
91,571 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2023-10-01 |
4 |
D |
$0.66 |
$2,146 |
D/D |
(3,241) |
182,910 |
|
- |
|
| Riley Anthony A |
Chief Financial Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
186,151 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-10-01 |
4 |
D |
$0.66 |
$1,624 |
D/D |
(2,453) |
1,704,371 |
|
- |
|
| Wagner Paul A. |
See Remarks |
• • – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
1,706,824 |
|
- |
|
76 Records found
|
|
Page 1 of 4 |
|
|
